Survival Outcomes Following Yttrium-90 and Holmium-166 Transarterial Radioembolization for Hepatocellular Carcinoma.

Cancers (Basel) · 2026 · PMC13360259 · PMID 42449586

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

Within this cohort, Ho-166 TARE showed a numerical trend toward improved PFS; however, no statistically significant differences in OS or PFS were observed between treatment groups in either univariable or multivariable analyses.

also in 723 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.